When was Azura Genomics founded?

Azura Genomics was founded in 2016.

Where is Azura Genomics located?

Azura Genomics is headquartered in Raynham, United States.

How many employees does Azura Genomics have?

As of Jul 01, 2024, the latest employee count at Azura Genomics is 3.

Is Azura Genomics a funded company?

Azura Genomics is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Azura Genomics rank among its competitors?

Azura Genomics ranks 75th amongst 149 active competitors, of which 18 are funded. The most recent competitor to raise funding was CleanNA, which secured an undisclosed amount in Sep, 2025.

Who are the top competitors of Azura Genomics?

Azura Genomics' top competitors include GenMark Diagnostics, NeuMoDx and ArcherDX. Among them, CleanNA secured the most recent funding round in September, 2025.

Azura Genomics - 2026 Company Profile & Competitors

Azura Genomics is an unfunded company based in Raynham (United States), founded in 2016. It operates as a Provider of reagents, kits, and instruments for molecular biology research. Azura Genomics has not raised any funding yet. The company has 149 active competitors, including 18 funded and 19 that have exited. Its top competitors include companies like GenMark Diagnostics, NeuMoDx and ArcherDX.

Company Details

Provider of reagents, kits, and instruments for molecular biology research. The company is focused on PCR, Real-Time PCR, Genotyping, and Cloning, with a product portfolio that includes the AzuraQuant gene expression and qPCR reagents, and others. Also, offers instrument systems such as MyGo real-time PCR system, myGel electrophoresis system, bead blaster homogenizer, MC12 Microcentrifuge, SmartDoc mini imaging system, myBlock heating blocks, and TC9639 Thermal Cycler.

Website: azuragenomics.com
Email ID: *****@azuragenomics.com
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

Raynham, United States

Stage

Unfunded

Ranked

75^th among 149 active competitors

Employee Count

3 as on Jul 01, 2024

Similar Companies

GenMark Diagnostics & 182 more

View Azura Genomics' full profile

Azura Genomics has not raised any funding rounds yet.

Azura Genomics' employee count trend

Azura Genomics has 3 employees as of Jul 24. Here is Azura Genomics's employee count trend over the years:

Uncover Azura Genomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Azura Genomics include GenMark Diagnostics, NeuMoDx and ArcherDX. Here is the list of Top 10 competitors of Azura Genomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	GenMark Diagnostics 1993, San Diego (United States), Acquired	Provider of instruments and test panels for multiplexed molecular diagnostics	$8.55M	SLR Investment Corp, VIDANT Capital	63/100
2nd	NeuMoDx 2012, Ann Arbor (United States), Acquired	Developer of a platform for low cost molecular testing	$66M	Arboretum Ventures, Pfizer Venture Investments ... & 3 others	58/100
3rd	ArcherDX 2013, Boulder (United States), Acquired	Developer of molecular cancer diagnostic products	$153M	Perceptive Advisors, PBM Capital & 8 others	53/100
4th	Biomeme 2013, Philadelphia (United States), Series A	Developer of a smartphone-based DNA detection platform	$6.2M	Ben Franklin Technology Partners, SeedFord Partners ... & 9 others	49/100
5th	KiOmed Pharma 2012, Herstal (Belgium), Series A	Developer of bio-polymer chitosan based products	$6.73M	SRIW, Noshaq	46/100
6th	miniPCR 2013, Cambridge (United States), Funding Raised	Developer of easy-to-use PCR and electrophoresis instruments	-	MassChallenge	45/100
7th	Invivoscribe 1995, San Diego (United States), Unfunded	Provider of molecular diagnostics for personalized medicine in oncology	-	-	46/100
8th	Third Wave Technologies 1993, Xiamen (China), Acquired	Molecular diagnostic test devices and reagents	$19.3M	SV Health Investors, Deerfield Triarc Capital ... & 1 others	42/100
9th	Diagnostic Hybrids 1983, Athens (United States), Acquired	Developer of molecular diagnostics kits for infectious diseases	$10M	Summit Partners, Kenson Ventures	41/100
10th	RNAConnect 2023, Branford (United States), Funding Raised	Provider of reverse transcriptase solutions for RNA analysis	-	HHS	41/100
75th	Azura Genomics 2016, Raynham (United States), Unfunded	Provider of reagents, kits, and instruments for molecular biology research	-	-	24/100